NCT02479880 - Utilization and Efficacy of Tenofovir DF in Adolescents With Chronic Hepatitis B Virus Infection | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 3, 2015

Primary Completion Date

February 28, 2018

Study Completion Date

April 11, 2018

Conditions

Hepatitis B

Interventions

DRUG

Tenofovir DF

300 mg tablet administered orally once daily for up to 96 weeks

RADIATION

DEXA Scan

Dual energy x-ray absorptiometry (DEXA) scans administered at protocol-specified time points

Trial Locations (11)

Cliniques Universitaries Saint- Luc, Departem Pediatrie, Brussels

Hospital Sant Joan de Déu, Barcelona

Grigore Alexandrescu Childrens Emergency Clinical Hospital, Bucharest

Attikon General Hospital Of Athens, Chaïdári

Hospital de Meixoeiro, Vigo

Azienda Ospedaliero-Universitaria di Bologna, Bologna

Hopital Femmes Meres Enfants, Bron

Institutul de Gastrenterologie si Hepatologie Iasi, Iași

Spitatul Clinic de Boli Infectioase Constanta, Constanța

Hospital Universitari Germans Trias i Pujol, Badalona

Birmingham Children's Hospital NHS Trust, Birmingham